NCT05944094View on ClinicalTrials.gov

Preterm Labor Prevention Using Vaginal Antiseptics Prior to 16 Weeks of Gestation

CompletedOBSERVATIONAL
Enrollment

1,117

Participants

Timeline

Start Date

June 1, 2021

Primary Completion Date

December 20, 2022

Study Completion Date

June 16, 2023

Conditions
Preterm Birth
Interventions
DEVICE

Clorhexidine

Antiseptic treatment aimed at reducing potential bacterial overgrowth consisted of 10 days (1 box) of vaginal ovules of CLX (CumLaude CLX ® , CLX digluconate 0.2%) always starting between 10+0 and 16+0 weeks.

Trial Locations (1)

46026

Hospital Uiversitario y Politécnico La Fe, Valencia

All Listed Sponsors
collaborator

Hospital Universitario La Fe

OTHER

lead

Instituto de Investigacion Sanitaria La Fe

OTHER